Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BREZTRI AEROSPHERE safely and effectively. See full prescribing information for BREZTRI AEROSPHERE.BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) inhalation aerosol, for oral inhalation useInitial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
BREZTRI AEROSPHERE is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. BREZTRI AEROSPHERE is indicated for the maintenance treatment of asthma in adult and pediatric patients 12 years of age and older. BREZTRI AEROSPHERE is not indicated for the relief of acute bronchospasm [see Warnings and Precautions (5.1, 5.2)].
- generic_name
- budesonide, glycopyrrolate, and formoterol fumarate
- product_names
- budesonide, glycopyrrolate, and formoterol fumarate
- ndc
- 0310-4616, 0310-4616-12, 0310-4616-39, 0310-4616-28, 0310-6616, 0310-6616-39, 0310-6616-01, 0310-6616-95
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en